Women @ RopesTalk: Conversation with Svetlana Lucas, Scribe Therapeutics

RopesTalk
22/05/2024 23 min
Women @ RopesTalk: Conversation with Svetlana Lucas, Scribe Therapeutics

Listen "Women @ RopesTalk: Conversation with Svetlana Lucas, Scribe Therapeutics"

Descargar episodio Ver en sitio original

Episode Synopsis


On this episode of Women @ RopesTalk hosted by IP transactions partner Megan Baca, IP transactions counsel Georgina Suzuki returns for another engaging conversation, this time with Svetlana Lucas, PhD, the chief business officer at Scribe Therapeutics, a biotech company that develops and engineers advanced CRISPR-based therapies for a wide range of diseases. Svetlana shares her journey in the biotech industry, the challenges and opportunities she has encountered, and her insights on the future of CRISPR technology. She also discusses the importance of relationships, diversity, and mentorship in the industry, and embracing the concept of “being comfortable with being uncomfortable.”

More episodes of the podcast RopesTalk

AI at Work – Smarter, Not Riskier: Employer Strategies for Responsible AI Use 03/12/2025
Decoding SFDR 2.0: Navigating the European Commission’s Proposed ESG Reforms 26/11/2025
Culture & Compliance Chronicles: Inside the Wirecard Scandal—Whistleblowing, Retaliation & Reform with Pav Gill 12/11/2025
Practical Considerations for Retirement Plan Sponsors Evaluating Alternative Assets in 401(k)s 30/10/2025
Non-Financial Misconduct Miniseries: Episode 1 - Navigating the FCA's Regulatory Framework 28/10/2025
Fully Invested: Key Features and Developments in ‘34 Act Funds 27/10/2025
Culture & Compliance Chronicles: Boardroom Agility—Strategies for Modern Boards Managing Crises, Compliance & Collective Responsibility 15/10/2025
Navigating Health Plan M&A: Strategies for Success in the Medicare Advantage Market 15/10/2025
Fully Invested: The Rise of CITs – Why They’re a Compelling Path for Asset Managers Entering the 401(k) Plan and Retail Markets 14/10/2025
Non-binding Guidance: The Administration’s Focus on Direct-to-Consumer Prescription Drug Advertising 06/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA